Epidemiologic and Genomic Surveillance of Vibrio cholerae and Effectiveness of Single-Dose Oral Cholera Vaccine, Democratic Republic of the Congo.

Bibliographic Details
Title: Epidemiologic and Genomic Surveillance of Vibrio cholerae and Effectiveness of Single-Dose Oral Cholera Vaccine, Democratic Republic of the Congo.
Authors: George, Christine Marie1 cmgeorge@jhu.edu, Namunesha, Alves2, Endres, Kelly1, Felicien, Willy2, Sanvura, Presence2, Bisimwa, Jean-Claude2, Perin, Jamie1, Bengehya, Justin3, Kulondwa, Jean Claude3, Maheshe, Ghislain2, Cikomola, Cirhuza2, Bisimwa, Lucien2, Mwishingo, Alain2, Sack, David A.1, Domman, Daryl4
Source: Emerging Infectious Diseases. Feb2025, Vol. 31 Issue 2, p288-297. 10p.
Subject Terms: *CHOLERA vaccines, *ORAL vaccines, *VIBRIO cholerae, *WHOLE genome sequencing, *VACCINE effectiveness
Geographic Terms: CONGO
Abstract: We conducted 4 years of epidemiologic and genomic surveillance of single-dose effectiveness of a killed whole-cell oral cholera vaccine (kOCV) and Vibrio cholerae transmission in the Democratic Republic of the Congo. We enrolled 1,154 patients with diarrhea; 342 of those had culture-confirmed cholera. We performed whole-genome sequencing on clinical and water V. cholerae isolates from 200 patient households, which showed annual bimodal peaks of V. cholerae clade AFR10e infections. A large clonal cholera outbreak occurred 14 months after a kOCV campaign of >1 million doses, likely because of low (9%) vaccine coverage in informal settlements. Clinical and water isolates collected in the same household were closely related, suggesting person-to-person and water-to-person transmission. Single-dose kOCV vaccine effectiveness 24 months after vaccination was 59.8% (95% CI 19.7%--79.9%), suggesting modest single-dose kOCV protection. kOCV campaigns combined with water, sanitation, and hygiene programs should be used to reduce cholera in disease-endemic settings worldwide. [ABSTRACT FROM AUTHOR]
Copyright of Emerging Infectious Diseases is the property of Centers for Disease Control & Prevention (CDC) and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)
Database: Academic Search Complete
More Details
ISSN:10806040
DOI:10.3201/eid3102.241777
Published in:Emerging Infectious Diseases
Language:English